This innovative screening method is completely non-invasive, i.e. no X-rays, no tracers in your body, no other extra tools and completely painless. The breast is not clamped between two plates or processed differently.

This is truly a woman-friendly breast screening method. With the worldwide patented and revolutionary technology, a highly sensitive image of the breast tissue is now made quickly and reliably. Deviations that are suspicious and / or that deserve attention for other reasons are made visible. The entire examination takes about 10 minutes, with the screening itself taking about 10 seconds. The result is immediately visible automatically, so that the client immediately knows whether there are deviations or not.

Due to the fully automatic diagnosis, it is possible to place this method in primary care, such as general practitioners. Because it is completely non-invasive, this research can be repeated more often without any risk, in order to better monitor hereditary persons. This screening method is suitable for any age, regardless of the density of the breast tissue. Pregnant women can also have a screening performed without any risk.

We proudly claim that this is the first truly reliable screening method, as an alternative to mammography and other existing methods.The first studies have shown that the Delseni can screen the breast with a high sensitivity.

Several clinical studies are now being conducted in various academic institutions, to scientifically substantiate this claim, to demonstrate that this is truly a perfect, non-invasive screening method for all ages.

These studies are expected to be completed by the end of 2020 and this screening method can be offered with the Delseni in regular care and beyond.

Current breast cancer research

One in eight women worldwide will be diagnosed with breast cancer in the course of their life. In 1990, the Netherlands introduced the ‘national breast cancer examination’ (bevolkingsonderzoek borstkanker) that invites all women aged between 50 and 75 to be screened for breast cancer every two years by means of a mammography. However, this approach has two drawbacks. Firstly, women under 50 tend to have very high tissue density in the breast area, which can distort the results of a mammography. Secondly, alongside potential pain during the examination, the harmful X-rays may have an adverse effect on patients’ health.

‘Delseni’: a new screening method

In response to this problem, Delseni BV has developed ‘Delseni’. Measuring vascularity (blood-vessel formation) in the breast, this screening method is also suitable for women aged 50 and below and aims to detect very early-onset breast cancer. Currently extensive clinical trials running to deliver the required clinical evidence.